USANA Health Sciences, Inc. USNA

14.50 0.24 1.68% as of 25 Sep
Market cap
$263.5M
P/E
0.0×

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Revenue

+8 more TTM periods

912.67 925.26 925.94 913.36
Cost of Revenue 190.00 200.85 207.84 206.00
Gross Profit 722.67 724.41 718.09 707.36
SG&A Expenses 680.85 680.01 675.49 672.34
Operating Income 41.82 37.43 35.64 (1.08)
Non-operating Income/Expense 5.96 4.10 4.62 3.62
Non-operating Interest Expenses 0.85 0.84 0.67 —
EBT 47.78 41.53 40.25 2.54
Income Tax Provision 30.22 30.05 31.11 31.79
Income after Tax 17.56 11.48 9.15 (29.25)
Net Income Common 16.99 10.76 8.87 (22.16)
EPS (Basic) 0.88 0.55 0.47 (1.21)
Gross Margin 79.18% 78.29% 77.55% 77.45%
EBIT Margin 4.58% 4.05% 3.85% (0.12%)
EBT margin 5.24% 4.49% 4.35% 0.28%
Net Profit Margin 1.86% 1.16% 0.96% (2.43%)
Free Cash Flow Margin 2.05% 1.34% 0.75% 2.18%
EBITDA 77.12 77.13 74.88 66.87
EBIT 41.82 37.43 35.64 (1.08)
EPS (Diluted, from Cont. Ops) 0.92 0.62 0.51 (1.57)
EPS (Basic, Consolidated) 0.92 0.62 0.51 (1.57)
EPS (Basic, from Continuous Ops) 0.92 0.62 0.51 (1.57)
Income from Continuous Operations 17.56 11.48 9.15 (29.25)
Consolidated Net Income/Loss 17.56 11.48 9.15 (29.25)
EBITDA Margin 8.45% 8.34% 8.09% 7.32%
Operating Cash Flow Margin 3.45% 2.42% 1.80% 3.04%

Fold the line items

In millions of $ except per-share values · columns are period end dates